Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory response of SARS-CoV-2 patients
暂无分享,去创建一个
F. Verdonk | B. Guidet | A. Tedgui | E. Maury | H. Ait-Oufella | M. Fartoukh | A. Pilon | M. Garnier | Y. Chantran | F. Fieux | G. Voiriot | Geoffroy Hariri | S. Thietart | G. Dumas | T. Urbina | N. Mario | Lucie Darrivere | J. Lavillegrand | M. Turpin | A. Spaeth | E. Berti | É. Maury
[1] C. Deutschman,et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes , 2020, The Lancet Respiratory Medicine.
[2] Keith Sigel,et al. An inflammatory cytokine signature predicts COVID-19 severity and survival , 2020, Nature Medicine.
[3] O. Cabrera-Marante,et al. IL-6–based mortality risk model for hospitalized patients with COVID-19 , 2020, Journal of Allergy and Clinical Immunology.
[4] S. Baldovino,et al. Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in severe patients with COVID-19. , 2020, Clinical and experimental rheumatology.
[5] S. Baldovino,et al. Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. , 2020 .
[6] R. Assaly,et al. Elevated interleukin‐6 and severe COVID‐19: A meta‐analysis , 2020, Journal of medical virology.
[7] Nils Kucher,et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy , 2020, Thrombosis Research.
[8] S. Alzghari,et al. Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review , 2020, Journal of Clinical Virology.
[9] M. Netea,et al. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure , 2020, Cell Host & Microbe.
[10] S. Merler,et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. , 2020, JAMA.
[11] Taojiao Wang,et al. Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. , 2020, The Journal of clinical investigation.
[12] J. Low,et al. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. , 2020, JAMA.
[13] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[14] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[15] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[16] J. Luyendyk,et al. The multifaceted role of fibrinogen in tissue injury and inflammation. , 2019, Blood.
[17] J. Ashworth,et al. Role of C-Reactive Protein at Sites of Inflammation and Infection , 2018, Front. Immunol..
[18] R. Bellomo,et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup , 2017, Nature Reviews Nephrology.
[19] Chuan Qin,et al. Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways , 2015, The Journal of infectious diseases.
[20] R. Baric,et al. Rapid generation of a mouse model for Middle East respiratory syndrome , 2014, Proceedings of the National Academy of Sciences.
[21] A. Osterhaus,et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. , 2012, The New England journal of medicine.
[22] Dohyeon Yu,et al. Kinetics of IL-6 and TNF-α changes in a canine model of sepsis induced by endotoxin. , 2012, Veterinary immunology and immunopathology.
[23] Christopher D. Paddock,et al. Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+ T Cells Are Important in Control of SARS-CoV Infection , 2009, Journal of Virology.
[24] D. Dwyer,et al. Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets , 2005, International Journal of Infectious Diseases.
[25] E. Yeh,et al. Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells , 2003, Circulation.
[26] J. Dorca,et al. Molecular Inflammatory Responses Measured in Blood of Patients with Severe Community-Acquired Pneumonia , 2003, Clinical Diagnostic Laboratory Immunology.
[27] Christian Drosten,et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.
[28] I. al Hifzi,et al. Isolated cerebrospinal fluid eosinophilia due to Streptococcus bovis meningitis in an infant. , 2002, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[29] C. Sprung,et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study , 1999, Intensive Care Medicine.
[30] U. Rüther,et al. Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. , 1997, The Biochemical journal.
[31] J. Kavanagh,et al. Kinetics of circulating TNF-alpha and TNF soluble receptors following surgery in a clinical model of sepsis. , 1996, Cytokine.
[32] S. Opal,et al. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. , 1996, The New England journal of medicine.
[33] S. Lemeshow,et al. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study , 1993 .
[34] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[35] S. Lemeshow,et al. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.